Skip to Main Content

Once again, Brent Saunders is standing out from the pharma c-suite crowd.

Over the weekend, the Allergan chief executive was the only head of a major drug maker to publicly say anything about the highly controversial Trump immigration ban. And what Saunders had to say was not supportive, at all, of the move: Allergan, he tweeted, “is strong & bold b/c of diversity. Oppose any policy that puts limitations on our ability to attract the best & diverse talent.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED